Welcome to Dermbits! Watch short videos of KOLs answering your questions

thumbnail_dermbits-colorful.png

dermbits-colorful.png

Dermbits

What were the efficacy outcomes for topical roflumilast in Phase 3 clinical trials?

Psoriasis

You. So approximately 40% of patients achieve clear or almost clear skin, and that's on generalized psoriasis. If you looked at specifically facial or intitrinous areas, and actually, while we didn't include facial, there are similar results there. But in intitrigenous areas at week 870, percent of patients achieve clear or almost clear, and approximately 60% of those were completely clear and.